COSIG CONFERENCE BROCHURE.pdf - Drexel University College ...
COSIG CONFERENCE BROCHURE.pdf - Drexel University College ... COSIG CONFERENCE BROCHURE.pdf - Drexel University College ...
COSIG Co-Occurring Disorders Conference, Hershey PA, May 15-17, 2006 Stage-Wise Treatment Sub-type II: SPMI +Substance Abuse Acute Interventions For severe MI decompensation, DDC IP unit. For substance use stabilization, no detox needed. For substance related symptomatic exacerbation of MI, without severe decompensation, DDC psychiatric crisis stabilization bed. Stage-Wise Treatment Sub-type II: SPMI +Substance Abuse Pre-Engagement, Engagement, Early Persuasion, Late Persuasion Interventions Individual MI, assuming role of DD recovery companion. Encourage participation in pre-motivational and persuasion groups. Involve families and other collaterals to support the motivational process and to promote interventions. Promote harm reduction and behavioral plans to promote contingency based learning, use payeeships,other contingencies. Stage-Wise Treatment Sub-type II: SPMI +Substance Abuse Pre-Engagement, Engagement, Early Persuasion, Late Persuasion Interventions Utilize negative consequences and adverse outcomes in a supportive context to promote learning and encourage change. Use best psychotropic medication available. Certain medication changes can be contingent upon reduced substance use. Harm reduction-housing (wet housing and damp housing) supports. Supported Employment (Individualized Placement & Support) for vocational rehabilitation. Stage-Wise Treatment Sub-type II: SPMI +Substance Abuse Action-Early Active TX and Late Active Interventions Continuing meds for MI, along w/appropriate TX supports: ind and grp, day TX/psych rehab, housing support, CM, etc. Emphasize building strengths/skills (including substance reduction skills) to promote recovery from MI. Cognitive-behavioral skills training (appropriate for level of psych disability) to promote substance reduction & elimination, in ind and grp settings integrated into MH TX. Skills training may be integrated into day treatment or psych rehab or CTT program. Stage-Wise Treatment Sub-type II: SPMI +Substance Abuse Action-Early Active TX and Late Active Interventions Abstinence is recommended goal, but appropriate outcome can be non-harmful use (e.g., alcohol
COSIG Co-Occurring Disorders Conference, Hershey PA, May 15-17, 2006 Motivational Interviewing • Motivational interviewing/counseling: An approach to counseling that helps to enhance motivation. Vignette # 2 Techniques can be used to help consumers to become motivated for mental health TX, or to make other changes in their lives. Is a consumer-centered counseling approach that aims to help individuals who aren't yet ready to change. Consumers can be seen NOT as "resistant" or "in denial" of their substance abuse or of their need for mental health TX but as needing help to increase their readiness to change behavior by linking change to their life goals. Results in remission of substance abuse for the majority of consumers who receive the TX. SAMHSA Integrated Dual Disorders Treatment Toolkit Principles of Motivational Interviewing Principles of Motivational Interviewing • Motivational interviewing uses five principles, which are always kept in mind during interactions with the consumer: Express empathy: actively listening without offering judgment, criticism, or advice. Develop discrepancy: identify and amplify discrepancy between behavior and goals through clarifying life goals and understanding the pros and cons to using that interferes with achieving goals. Avoid argumentation: the principle is to avoid arguments in general, with the assumption that arguments simply strengthen people's beliefs, rather than helping them change their beliefs. Roll with resistance: It is important to let the consumer express his/her differing opinions and to "roll with it" instead of trying to fight it. Support self-efficacy: Self-efficacy is the belief that one can succeed at change. The final principle in motivational interviewing is to support the client's self-efficacy. This is particularly critical for people who are demoralized, depressed, or hopeless. SAMHSA Integrated Dual Disorders Treatment Toolkit SAMHSA Integrated Dual Disorders Treatment Toolkit Harm Reduction Housing Vignette # 3 • No eject, no reject • Housing for housing sake • Stage-wise treatment and supports • Safe, affordable • Stage specific (wet and damp, substance free) 7
- Page 345 and 346: Article by Kenneth Minkoff, MD and
- Page 347 and 348: Article by Kenneth Minkoff, MD and
- Page 349 and 350: Article by Kenneth Minkoff, MD and
- Page 351 and 352: Article by Kenneth Minkoff, MD and
- Page 353 and 354: RESOURCE BIBLIOGRAPHY (2005) 1. Ame
- Page 355 and 356: 38. Foundation Associates, Making M
- Page 357 and 358: 71. Minkoff K & Cline C, Developing
- Page 359 and 360: co-occurring psychiatric and substa
- Page 361: T31: Implementing Evidence-Based Pr
- Page 364 and 365: COSIG Co-Occurring Disorders Confer
- Page 366 and 367: COSIG Co-Occurring Disorders Confer
- Page 368 and 369: COSIG Co-Occurring Disorders Confer
- Page 371: T32: Berks County Adolescent Pilot
- Page 374 and 375: COSIG Co-Occurring Disorders Confer
- Page 376 and 377: COSIG Co-Occurring Disorders Confer
- Page 379 and 380: COSIG Co-Occurring Disorders Confer
- Page 381 and 382: COSIG Co-Occurring Disorders Confer
- Page 383 and 384: COSIG Co-Occurring Disorders Confer
- Page 385 and 386: COSIG Co-Occurring Disorders Confer
- Page 387: COSIG Co-Occurring Disorders Confer
- Page 391 and 392: COSIG Co-Occurring Disorders Confer
- Page 393 and 394: COSIG Co-Occurring Disorders Confer
- Page 395: COSIG Co-Occurring Disorders Confer
- Page 399: T35: CCISC Implementation in Pennsy
- Page 402 and 403: COSIG Co-Occurring Disorders Confer
- Page 404 and 405: COSIG Co-Occurring Disorders Confer
- Page 406 and 407: COSIG Co-Occurring Disorders Confer
- Page 408 and 409: COSIG Co-Occurring Disorders Confer
- Page 410 and 411: Volume 1, Issue 5 The Trainers meet
- Page 412 and 413: Volume 1, Issue 1 BLAIR COUNTY’S
- Page 414 and 415: Volume 1, Issue 1 Vision/Mission CO
- Page 416 and 417: Volume 1, Issue 1 3. The population
- Page 418 and 419: Volume 1, Issue 1 Complete
- Page 420 and 421: Volume 1, Issue 1 The forgoing Cons
- Page 422 and 423: Volume 1, Issue 1 Language for Inte
- Page 424 and 425: Volume 1, Issue 1 Language for Inte
- Page 427: T36: The Co-Occurring Distinction:
- Page 430 and 431: Integration or Occupation? •QUEST
- Page 432 and 433: Coming to a Balance “Rather shall
- Page 435 and 436: COSIG Co-Occurring Disorders Confer
- Page 437 and 438: COSIG Co-Occurring Disorders Confer
- Page 439 and 440: COSIG Co-Occurring Disorders Confer
- Page 441 and 442: COSIG Co-Occurring Disorders Confer
- Page 443 and 444: COSIG Co-Occurring Disorders Confer
- Page 445 and 446: COSIG Co-Occurring Disorders Confer
<strong>COSIG</strong> Co-Occurring Disorders Conference, Hershey PA, May 15-17, 2006<br />
Stage-Wise Treatment<br />
Sub-type II: SPMI +Substance Abuse<br />
<br />
<br />
<br />
<br />
Acute Interventions<br />
For severe MI decompensation, DDC IP unit.<br />
For substance use stabilization, no detox needed.<br />
For substance related symptomatic exacerbation of MI,<br />
without severe decompensation, DDC psychiatric crisis<br />
stabilization bed.<br />
Stage-Wise Treatment<br />
Sub-type II: SPMI +Substance Abuse<br />
Pre-Engagement, Engagement, Early Persuasion, Late<br />
Persuasion Interventions<br />
<br />
<br />
<br />
<br />
Individual MI, assuming role of DD recovery companion.<br />
Encourage participation in pre-motivational and persuasion<br />
groups.<br />
Involve families and other collaterals to support the<br />
motivational process and to promote interventions.<br />
Promote harm reduction and behavioral plans to promote<br />
contingency based learning, use payeeships,other<br />
contingencies.<br />
Stage-Wise Treatment<br />
Sub-type II: SPMI +Substance Abuse<br />
Pre-Engagement, Engagement, Early Persuasion, Late<br />
Persuasion Interventions<br />
<br />
<br />
<br />
<br />
Utilize negative consequences and adverse outcomes in a<br />
supportive context to promote learning and encourage<br />
change.<br />
Use best psychotropic medication available. Certain<br />
medication changes can be contingent upon reduced<br />
substance use.<br />
Harm reduction-housing (wet housing and damp housing)<br />
supports.<br />
Supported Employment (Individualized Placement &<br />
Support) for vocational rehabilitation.<br />
Stage-Wise Treatment<br />
Sub-type II: SPMI +Substance Abuse<br />
<br />
<br />
<br />
<br />
<br />
Action-Early Active TX and Late Active Interventions<br />
Continuing meds for MI, along w/appropriate TX supports:<br />
ind and grp, day TX/psych rehab, housing support, CM, etc.<br />
Emphasize building strengths/skills (including substance<br />
reduction skills) to promote recovery from MI.<br />
Cognitive-behavioral skills training (appropriate for level of<br />
psych disability) to promote substance reduction &<br />
elimination, in ind and grp settings integrated into MH TX.<br />
Skills training may be integrated into day treatment or psych<br />
rehab or CTT program.<br />
Stage-Wise Treatment<br />
Sub-type II: SPMI +Substance Abuse<br />
<br />
<br />
<br />
Action-Early Active TX and Late Active<br />
Interventions<br />
Abstinence is recommended goal, but appropriate<br />
outcome can be non-harmful use (e.g., alcohol<br />